Literature DB >> 27843970

Ascorbic acid in septic shock.

Hossein Khalili1.   

Abstract

Entities:  

Year:  2016        PMID: 27843970      PMCID: PMC5084491          DOI: 10.4103/2279-042X.192452

Source DB:  PubMed          Journal:  J Res Pharm Pract        ISSN: 2279-042X


× No keyword cloud information.
Dear Editor, Regarding our recent published article in Journal of Research in Pharmacy Practice (Hosseini Zabet M, et al. Effect of high-dose Ascorbic acid on vasopressor's requirement in septic shock. J Res Pharm Pract 2016; 5(2):94-100), I would like to explain some points: Sepsis is a leading cause of mortality in critically ill patients. Most patients with severe sepsis or septic shock almost always require vasoactive agents to maintain vital organs perfusion.[1] Reduced response to the available vasopressors has been proposed in these life-threatening conditions.[23] Potential benefits of Vitamin C as a potent antioxidant were evaluated in several populations of critically ill patients. In some of the studies, Vitamin C improved vasopressors responses.[456] Carr et al. recently collected the available evidence and proposed ascorbate-dependent vasopressor synthesis as the main mechanism for Vitamin C in severe sepsis and septic shock. This review was published in November 2015 at Journal of “Critical Care.”[7] Most available evidence regarding the role of Vitamin C in severe sepsis and septic shock came from nonsurgical critically ill populations.[456] Evaluating the effect of high-dose Vitamin C in reducing vasopressor requirement in septic shock in surgical critically ill patients was registered as a Pharm D student thesis at November 17, 2014, in Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran (ID: 93/d/230/4311). The results of this project were presented and approved on May 14, 2016 (ID registration: 5436). The results were also published in Journal of Research in Pharmacy Practice 2016.[8] In this study, high-dose Vitamin C significantly reduced vasopressor requirement in surgical critically ill patients. This study was a pilot clinical study. In the published article,[8] authors mentioned mechanisms that have been proposed previously by Carr et al.[7] and others[46] for the probable role of Vitamin C in severe sepsis and septic shock, including antioxidant and anti-inflammatory properties of Vitamin C, cortisol sparing effect, inhibitory effect on nitric oxide synthase and increasing catecholamines synthesis in the brain and adrenal medulla. In drafting of our very recent article,[8] related original articles were referred to, but the review article of Carr [7] was missed. This article also should have been cited for paragraph numbers 3, 4, 6, and 7 in our study.[8] Hereby, we thank them for their comprehensive review article, which regrettably was missed to acknowledge properly in our article. However, there are several gaps regarding the definite role of Vitamin C in severe sepsis and septic shock. The optimum time for adding Vitamin C, dose of Vitamin C, method of administration (bolus or continuous infusion), vasopressors' dependent response and different critically ill populations with severe sepsis and septic shock may be considered in future studies.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  7 in total

1.  Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.

Authors:  A Petros; D Bennett; P Vallance
Journal:  Lancet       Date:  1991 Dec 21-28       Impact factor: 79.321

2.  Ascorbic acid efficiently enhances neuronal synthesis of norepinephrine from dopamine.

Authors:  James M May; Zhi-Chao Qu; Rafal Nazarewicz; Sergey Dikalov
Journal:  Brain Res Bull       Date:  2012-09-26       Impact factor: 4.077

3.  Terlipressin for norepinephrine-resistant septic shock.

Authors:  Alastair O'Brien; Lucie Clapp; Mervyn Singer
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

Review 4.  Evaluation of vitamin C for adjuvant sepsis therapy.

Authors:  John X Wilson
Journal:  Antioxid Redox Signal       Date:  2013-06-25       Impact factor: 8.401

5.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

6.  Effect of high-dose Ascorbic acid on vasopressor's requirement in septic shock.

Authors:  Mohadeseh Hosseini Zabet; Mostafa Mohammadi; Masoud Ramezani; Hossein Khalili
Journal:  J Res Pharm Pract       Date:  2016 Apr-Jun

7.  Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?

Authors:  Anitra C Carr; Geoffrey M Shaw; Alpha A Fowler; Ramesh Natarajan
Journal:  Crit Care       Date:  2015-11-27       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.